Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Newstrike Brands Ltd NWKRF

Healthcare Biotechnology Cannabis
"Newstrike Brands Ltd is a licensed producer and cultivator of medical cannabis based in Brantford, Ontario. The company cultivates and sells both forms including dried and fresh marihuana."


OTCPK:NWKRF - Post by User

Newstrike Brands Ltd > Did I read this correctly?
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Comment by Gulruthinaon Jan 05, 2018 8:28pm
133 Views
Post# 27294951

RE:RE:RE:RE:RE:RE:RE:RE:Did I read this correctly?

RE:RE:RE:RE:RE:RE:RE:RE:Did I read this correctly?TORONTO, ONTARIO--(Marketwired - Nov. 27, 2017) - Newstrike Resources Ltd. (TSX VENTURE:HIP) ("Newstrike" or the "Company"), together with its wholly-owned subsidiary, Up Cannabis Inc. ("Up Cannabis"), a licensed producer of cannabis under the Access to Cannabis for Medical Purposes Regulations, is issuing the following statement to provide additional details regarding its pending acquisition (the "Transaction") by CanniMed Therapeutics Inc. (TSX:CMED) ("CanniMed"), announced on November 17, 2017. As previously announced, each Newstrike shareholder will receive 33 CanniMed shares for every 1,000 Newstrike shares held.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities